Delivery Order SPE2DB22D9112-SPE2DB25FTKRH
- Not listed
- The Defense Logistics Agency awarded a $38,685 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of XOLAIR 150 mg/ml syringes. This firm fixed-price delivery order, issued on September 17, 2025, with an ultimate completion date of October 8, 2025, represents a discrete purchase under the agency's broader pharmaceutical supply framework. The contract contains no set-aside designation, allowing...
- The Defense Logistics Agency awarded a $1,547.40 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of XOLAIR 150 mg/ml syringes. The contract is firm fixed-price with an ultimate completion date of September 18, 2025, and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at approximately $500 million...
- The Defense Logistics Agency awarded a $74.3K delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. The award, issued on August 21, 2025, represents a firm fixed-price delivery order under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $500M and valid through November 2026. This delivery order carries an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $37,137.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order, issued on August 26, 2025, carries an ultimate completion date of September 17, 2025, with performance occurring at the vendor's Park Ridge facility. The award was made without a set-aside designation, allowing DMS...
- The Defense Logistics Agency awarded a $37.5K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL syringes. This delivery order, which is expected to be completed by September 11, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group is performing the work at its Park Ridge, Illinois location and will deliver this biologic medication to...
- The Defense Logistics Agency awarded a delivery order valued at $12,379.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, was awarded without set-aside designation. DMS Pharmaceutical Group is registered in the System for Award Management and has maintained...
- The Defense Logistics Agency has awarded a delivery order valued at $3,868.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the provision of Xolair 150 mg/ml syringes. The contract is firm fixed-price with an ultimate completion date of September 17, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order, valued at $1,547.40 with an ultimate completion date of September 10, 2025, was issued without set-aside designation. DMS Pharmaceutical Group competes effectively in federal procurement leveraging its small business status and established...
- The Defense Logistics Agency awarded a delivery order valued at $1,547.40 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml syringes. The award, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, is structured as a firm fixed-price delivery order without any set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will fulfill this order for delivery to...
- The Defense Logistics Agency awarded a $4,642.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. The contract, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at...
- SPE2DB22D9112Indefinite Delivery Contract
- SPE2DB22D9112-SPE2DB25FTKRHDelivery Order
The Defense Logistics Agency awarded a $1,547.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. This delivery order, issued on September 24, 2025, with an ultimate completion date of October 16, 2025, carries no set-aside designation. The award leverages DMS Pharmaceutical Group's position as a critical supplier within the federal pharmaceutical supply chain, with delivery performance to be executed at the vendor's Park Ridge facility. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and extending through November 2026. The IDC enables the Defense Logistics Agency to issue firm fixed-price delivery orders for an extensive portfolio of pharmaceutical products supporting Department of Defense healthcare facilities worldwide, encompassing prescription medications, biologics, over-the-counter medications, and medical consumables. As a woman-owned small business with federal contract experience dating to 2001, DMS Pharmaceutical Group has consistently demonstrated capability in delivering specialized pharmaceutical products, including immunology treatments such as Xolair, to military health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/24/25 |